{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:41:30Z","timestamp":1794346890735,"version":"4.9.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI133706"],"award-info":[{"award-number":["R01AI133706"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI164566"],"award-info":[{"award-number":["UM1AI164566"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["RR000165\/OD011132"],"award-info":[{"award-number":["RR000165\/OD011132"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["P30AI050409"],"award-info":[{"award-number":["P30AI050409"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007813","name":"Center for AIDS Research, University of Washington","doi-asserted-by":"publisher","award":["U42PDP11023"],"award-info":[{"award-number":["U42PDP11023"]}],"id":[{"id":"10.13039\/100007813","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102636","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:47:15Z","timestamp":1771948035000},"page":"102636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Delayed viral rebound post-ART interruption in infant macaques given SIV-specific neutralizing antibodies"],"prefix":"10.1016","volume":"7","author":[{"given":"Jenna S.","family":"Powers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Bricker-Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Obregon-Perko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dormarie E.","family":"Rivera Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Sukkestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshita Lopez","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Dashti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleaha","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo A.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cotsonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk A.","family":"Easley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate S.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay R.","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renguang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Fennessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon F.","family":"Keele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie D.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Roederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7479-9546","authenticated-orcid":false,"given":"Ann","family":"Chahroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102636_bib1","unstructured":"UNAIDS. Global HIV & AIDS statistics\u2014Fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet#:\u223c:text=Global%20HIV%20statistics,AIDS%2Drelated%20illnesses%20in%202024"},{"key":"10.1016\/j.xcrm.2026.102636_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3390\/v13061134","article-title":"HIV-1 Persistence in Children during Suppressive ART","volume":"13","author":"Katusiime","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2026.102636_bib3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.clp.2024.08.006","article-title":"Research Toward a Cure for Perinatal HIV","volume":"51","author":"Kelly","year":"2024","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.xcrm.2026.102636_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12981-025-00734-8","article-title":"Clinical trials of broadly neutralizing monoclonal antibodies in people living with HIV - a review","volume":"22","author":"Mahomed","year":"2025","journal-title":"AIDS Res. Ther."},{"key":"10.1016\/j.xcrm.2026.102636_bib5","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with anti-HIV-1 antibodies maintains viral suppression","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102636_bib7","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41591-024-03247-5","article-title":"Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1\/2a trial","volume":"30","author":"Julg","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature18929","article-title":"HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption","volume":"535","author":"Scheid","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102636_bib9","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1016\/S2352-3018(23)00293-X","article-title":"Safety of teropavimab and zinlirvimab with lenacapavir once every 6 months for HIV treatment: a phase 1b, randomised, proof-of-concept study","volume":"11","author":"Eron","year":"2024","journal-title":"Lancet HIV"},{"key":"10.1016\/j.xcrm.2026.102636_bib10","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/s41591-023-02547-6","article-title":"Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial","volume":"29","author":"Gunst","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib11","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","article-title":"Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial","volume":"28","author":"Gunst","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib12","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/COH.0000000000000806","article-title":"Antibody interventions in HIV: broadly neutralizing mAbs in children","volume":"18","author":"Ajibola","year":"2023","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.xcrm.2026.102636_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh0004","article-title":"Broadly neutralizing antibody treatment maintained HIV suppression in children with favorable reservoir characteristics in Botswana","volume":"15","author":"Shapiro","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/COH.0000000000000731","article-title":"An exploration of how broadly neutralizing antibodies might induce HIV remission: the \u2018vaccinal\u2019 effect","volume":"17","author":"Tipoe","year":"2022","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.xcrm.2026.102636_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imr.12074","article-title":"Immunology of pediatric HIV infection","volume":"254","author":"Tobin","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.xcrm.2026.102636_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11904-023-00686-6","article-title":"More than the Infinite Monkey Theorem: NHP Models in the Development of a Pediatric HIV Cure","volume":"21","author":"Fonseca","year":"2024","journal-title":"Curr. HIV AIDS Rep."},{"key":"10.1016\/j.xcrm.2026.102636_bib17","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1038\/s41591-023-02570-7","article-title":"AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques","volume":"29","author":"Dashti","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib18","article-title":"Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability","volume":"12","author":"Mason","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102636_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010574","article-title":"Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4","volume":"18","author":"Welles","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102636_bib20","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2404767122","article-title":"SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variants","volume":"122","author":"King","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102636_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011407","article-title":"Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein","volume":"19","author":"Grunst","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102636_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.chom.2018.12.001","article-title":"HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design","volume":"25","author":"Bricault","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2026.102636_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41591-019-0747-1","article-title":"Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity","volume":"26","author":"Niessl","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib24","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/s41467-022-34171-2","article-title":"Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8(+) T cell immunity","volume":"13","author":"Rosas-Umbert","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102636_bib25","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaci.2015.03.013","article-title":"Monoclonal antibodies in excess: A simple way to avoid immunogenicity in patients?","volume":"136","author":"Chaigne","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.xcrm.2026.102636_bib26","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.aaf0972","article-title":"HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1","volume":"352","author":"Schoofs","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102636_bib27","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.adf7966","article-title":"Induction of durable remission by dual immunotherapy in SHIV-infected ART-suppressed macaques","volume":"383","author":"Lim","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102636_bib28","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201214","article-title":"Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia","volume":"218","author":"Nishimura","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib29","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1128\/jvi.68.9.6103-6110.1994","article-title":"Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection","volume":"68","author":"Borrow","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.102636_bib30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/370416a0","article-title":"Shutting down HIV","volume":"370","author":"Koup","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102636_bib31","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102636_bib32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.immuni.2008.10.010","article-title":"Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control","volume":"29","author":"Migueles","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102636_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/QAI.0b013e3181e69609","article-title":"Evolution of the functional profile of HIV-specific CD8+ T cells in patients with different progression of HIV infection over 4 years","volume":"55","author":"Peris-Pertusa","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.xcrm.2026.102636_bib34","doi-asserted-by":"crossref","DOI":"10.2174\/011570162X362665250727012610","article-title":"HIV-1 bNAb Vaccinal Effect - An Underachieving Goal?","author":"King","year":"2025","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.xcrm.2026.102636_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011861","article-title":"Using viral sequence diversity to estimate time of HIV infection in infants","volume":"19","author":"Russell","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2026.102636_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01699-21","article-title":"Altered Response Pattern following AZD5582 Treatment of SIV-Infected, ART-Suppressed Rhesus Macaque Infants","volume":"96","author":"Bricker","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.xcrm.2026.102636_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110174","article-title":"Compartment-specific antibody correlates of protection to SARS-CoV-2 Omicron in macaques","volume":"27","author":"Tong","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2026.102636_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu7646","article-title":"Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques","volume":"17","author":"Jacob-Dolan","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ady2282","article-title":"An intramuscular prime and mucosal boost vaccine regimen protects against lethal clade 2.3.4.4b H5N1 challenge in cynomolgus macaques","volume":"17","author":"Lasrado","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102636_bib40","article-title":"Enhanced detection of antigen-specific T cells by a multiplexed AIM assay","volume":"4","author":"Lemieux","year":"2024","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.xcrm.2026.102636_bib41","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","article-title":"Intracellular cytokine optimization and standard operating procedure","volume":"1","author":"Lamoreaux","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.102636_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/imcb.12636","article-title":"T-cell activation-induced marker assays in health and disease","volume":"101","author":"Poloni","year":"2023","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.xcrm.2026.102636_bib43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.ijo.0801839","article-title":"A comparison of methods for analyzing glucose and insulin areas under the curve following nine months of exercise in overweight adults","volume":"26","author":"Potteiger","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:23:41Z","timestamp":1783095821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2666379126000534"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102636","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delayed viral rebound post-ART interruption in infant macaques given SIV-specific neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102636","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102636"}}